Kenya is accelerating plans to fully integrate its HIV response into a unified national health system after a donor funding…
The Global Fund has cut funding for Kenya's HIV programme by 18.2 percent to Sh26.4 billion ($205million) over the next…
Kenya has received a Sh256 million ($2 million) grant from the Global Fund to support the nationwide distribution of Lenacapavir,…
Kenya has begun a new phase in its HIV prevention strategy with the introduction of Lenacapavir, a long-acting injectable pre-exposure…
Kenya has initiated a phased rollout of Lenacapavir, a long-acting injectable medicine for HIV prevention. The government’s action marks a…